chr5-177604405-C-T

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_007255.3(B4GALT7):​c.277C>T​(p.His93Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.00224 in 1,613,858 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0014 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0023 ( 10 hom. )

Consequence

B4GALT7
NM_007255.3 missense

Scores

4
8
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:3O:1

Conservation

PhyloP100: 7.11
Variant links:
Genes affected
B4GALT7 (HGNC:930): (beta-1,4-galactosyltransferase 7) This gene is a member of the beta-1,4-galactosyltransferase (beta4GalT) family. Family members encode type II membrane-bound glycoproteins that appear to have exclusive specificity for the donor substrate UDP-galactose. Each beta4GalT member has a distinct function in the biosynthesis of different glycoconjugates and saccharide structures. As type II membrane proteins, they have an N-terminal hydrophobic signal sequence that directs the protein to the Golgi apparatus which then remains uncleaved to function as a transmembrane anchor. The enzyme encoded by this gene attaches the first galactose in the common carbohydrate-protein linkage (GlcA-beta1,3-Gal-beta1,3-Gal-beta1,4-Xyl-beta1-O-Ser) found in proteoglycans. This enzyme differs from other beta4GalTs because it lacks the conserved Cys residues found in beta4GalT1-beta4GalT6 and it is located in cis-Golgi instead of trans-Golgi. Mutations in this gene have been associated with the progeroid form of Ehlers-Danlos syndrome. [provided by RefSeq, Oct 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.032865435).
BP6
Variant 5-177604405-C-T is Benign according to our data. Variant chr5-177604405-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 374581.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=3, not_provided=1}. Variant chr5-177604405-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00142 (217/152324) while in subpopulation NFE AF= 0.00271 (184/68016). AF 95% confidence interval is 0.00239. There are 0 homozygotes in gnomad4. There are 100 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 10 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
B4GALT7NM_007255.3 linkuse as main transcriptc.277C>T p.His93Tyr missense_variant 2/6 ENST00000029410.10 NP_009186.1 Q9UBV7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
B4GALT7ENST00000029410.10 linkuse as main transcriptc.277C>T p.His93Tyr missense_variant 2/61 NM_007255.3 ENSP00000029410.5 Q9UBV7

Frequencies

GnomAD3 genomes
AF:
0.00143
AC:
217
AN:
152206
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000386
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000847
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00270
Gnomad OTH
AF:
0.00240
GnomAD3 exomes
AF:
0.00138
AC:
341
AN:
246966
Hom.:
1
AF XY:
0.00142
AC XY:
190
AN XY:
134138
show subpopulations
Gnomad AFR exome
AF:
0.000189
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.000700
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000694
Gnomad NFE exome
AF:
0.00280
Gnomad OTH exome
AF:
0.000494
GnomAD4 exome
AF:
0.00232
AC:
3392
AN:
1461534
Hom.:
10
Cov.:
48
AF XY:
0.00219
AC XY:
1594
AN XY:
727104
show subpopulations
Gnomad4 AFR exome
AF:
0.000209
Gnomad4 AMR exome
AF:
0.000157
Gnomad4 ASJ exome
AF:
0.000575
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00137
Gnomad4 NFE exome
AF:
0.00290
Gnomad4 OTH exome
AF:
0.00114
GnomAD4 genome
AF:
0.00142
AC:
217
AN:
152324
Hom.:
0
Cov.:
33
AF XY:
0.00134
AC XY:
100
AN XY:
74484
show subpopulations
Gnomad4 AFR
AF:
0.000385
Gnomad4 AMR
AF:
0.000196
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000847
Gnomad4 NFE
AF:
0.00271
Gnomad4 OTH
AF:
0.00237
Alfa
AF:
0.00210
Hom.:
1
Bravo
AF:
0.00124
TwinsUK
AF:
0.00351
AC:
13
ALSPAC
AF:
0.00415
AC:
16
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00244
AC:
21
ExAC
AF:
0.00156
AC:
189

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:3Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Ehlers-Danlos syndrome progeroid type Uncertain:1Benign:1Other:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsOct 31, 2018- -
not provided, no classification providedphenotyping onlyGenomeConnect, ClinGen-GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitterclinical testingGeneDxSep 23, 2021In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 32214361) -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024B4GALT7: BS2 -
Ehlers-Danlos syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenMay 27, 2021- -
B4GALT7-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesFeb 17, 2024This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.26
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Uncertain
-0.050
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.19
T;.
Eigen
Pathogenic
0.70
Eigen_PC
Uncertain
0.65
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.93
D;D
M_CAP
Benign
0.046
D
MetaRNN
Benign
0.033
T;T
MetaSVM
Benign
-0.76
T
MutationAssessor
Uncertain
2.3
M;.
PrimateAI
Pathogenic
0.87
D
PROVEAN
Pathogenic
-5.2
D;D
REVEL
Uncertain
0.32
Sift
Uncertain
0.0010
D;D
Sift4G
Uncertain
0.059
T;D
Polyphen
1.0
D;.
Vest4
0.79
MVP
0.44
MPC
0.68
ClinPred
0.44
T
GERP RS
4.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.85
gMVP
0.85

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs142476892; hg19: chr5-177031406; COSMIC: COSV50355854; COSMIC: COSV50355854; API